Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
Volume 0.52M
Average 1.46M
NNOX Sales of Investments
Cash received from selling or redeeming investments.
Nano-X Imaging Ltd.NASDAQ: NNOX
Sales of Investments · Q4 FY2025 · quarter ended Dec 2025
Sales of investments growth accelerates
Q4 FY2025 sales of investments of $506.37K rose 103.4% year over year, ahead of the -13.3% change in trailing-twelve-month sales of investments. Sequentially, it fell 85.1% from the prior quarter. Over 3 fiscal years it compounded at +2.7% a year.
Context
- Sales of investments amounted to 259.5% of revenue in FY2025, down 105.5 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +103.4% holds above the trailing-twelve-month pace of -13.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 33.8M USD
- Year-over-year change
- -17.9%
- 4-year CAGR
- -21.8%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 33.8M | -17.9% |
| FY2024 | 2024-12-31 | 41.19M | +5.3% |
| FY2023 | 2023-12-31 | 39.11M | +25.2% |
| FY2022 | 2022-12-31 | 31.24M | -65.4% |
| FY2021 | 2021-12-31 | 90.3M | — |
Sales of Investments vs competitors
How NNOX compares with its peers on the latest reported figures
- NNOX's LTM Dec 2025 sales of investments of $35.69M is the 6th largest of the 11 companies compared; the peer median is $30.21M.
- Its year-over-year change of -13.3% is the 2nd highest of 7, against a peer median of -39.1%.
- Sales of investments amounts to 274.1% of revenue for NNOX, versus a peer median of 35.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $199.89M | +99.0% | — | 32344.2% | |
| LTM Mar 2026 | $167.92M | -35.6% | — | 115.9% | |
| LTM Mar 2026 | $137.57M | -42.6% | -14.9% | 117.0% | |
| LTM Mar 2026 | $137.16M | -20.1% | -18.2% | 424.8% | |
| LTM Mar 2026 | $41.74M | -83.2% | -19.6% | 13.8% | |
| LTM Dec 2025 | $35.69M | -13.3% | +2.7% | 274.1% | |
| LTM Mar 2026 | $18.67M | -42.5% | +11.8% | 5.3% | |
| LTM Mar 2026 | $5.47M | — | — | 57.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NNOX) | $30.21M | -39.1% | -16.6% | 35.4% | |
Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| Deferred Income Tax | (116K) | (3.73M) | (377K) | (377K) | (1.98M) |
| Stock-Based Compensation | 18.81M | 18.62M | 6.84M | 7.26M | 4.19M |
| Change in Working Capital | 2.75M | (16.95M) | (7.48M) | (1.13M) | 2.77M |
| Accounts Receivables | (40K) | 74K | (507K) | (321K) | 107K |
| Inventory | 864K | 0 | 0 | (277K) | (325K) |
| Accounts Payables | 1.72M | 469K | (153K) | (1.32M) | 288K |
| Other Working Capital | 202K | (17.49M) | (6.82M) | 787K | 2.7M |
| Other Non-Cash Items | (2K) | 52.4M | 5.21M | (572K) | 17.54M |
| Operating Cash Flow | (38.07M) | (43.39M) | (44.78M) | (36.6M) | (40.79M) |
| Capital Expenditures | (23.16M) | (7.17M) | (3.3M) | (2.77M) | (4.21M) |
| Acquisitions (Net) | (2.86M) | 1.01M | 0 | 0 | 0 |
| Purchases of Investments | (90.3M) | (9.46M) | (373K) | (58.52M) | (15K) |
| Sales of Investments | 90.3M | 31.24M | 39.11M | 41.19M | 33.8M |
| Other Investing Activities | (90.3M) | (1.01M) | (373K) | 46K | (200K) |
| Investing Cash Flow | (116.32M) | 14.61M | 35.43M | (20.05M) | 29.37M |
| Debt Repayment | 3.8M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 3.58M | 949K | 27.14M | 37.83M | 21.37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.58M | 804K | 113K | 1.67M | 0 |
| Financing Cash Flow | 7.38M | 804K | 27.25M | 39.5M | 21.37M |
| Effect of Forex Changes | (10K) | (268K) | (60K) | 72K | (101K) |
| Net Change in Cash | (147.01M) | (28.24M) | 17.85M | (17.07M) | 9.85M |
| Free Cash Flow | (61.23M) | (50.56M) | (48.08M) | (39.37M) | (45M) |
Nano-X Imaging Ltd.
NASDAQ:NNOX
Intrinsic Alpha fair value
Locked
Current Price
$0.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.